These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31808848)

  • 1. Management of rare acquired bleeding disorders.
    Menegatti M; Biguzzi E; Peyvandi F
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):80-87. PubMed ID: 31808848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy.
    Cugno M; Gualtierotti R; Tedeschi A; Meroni PL
    Autoimmun Rev; 2014 Jan; 13(1):40-8. PubMed ID: 23954454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in managing rare acquired bleeding disorders.
    Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
    Expert Rev Hematol; 2020 Jun; 13(6):599-606. PubMed ID: 32286895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired inhibitors.
    Cohen AJ; Kessler CM
    Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.
    Peyvandi F; Palla R; Menegatti M; Siboni SM; Halimeh S; Faeser B; Pergantou H; Platokouki H; Giangrande P; Peerlinck K; Celkan T; Ozdemir N; Bidlingmaier C; Ingerslev J; Giansily-Blaizot M; Schved JF; Gilmore R; Gadisseur A; Benedik-Dolničar M; Kitanovski L; Mikovic D; Musallam KM; Rosendaal FR;
    J Thromb Haemost; 2012 Apr; 10(4):615-21. PubMed ID: 22321862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnosis and classification of autoimmune coagulopathy: an updated review.
    Chang HH; Chiang BL
    Autoimmun Rev; 2014; 13(4-5):587-90. PubMed ID: 24424199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing rare bleeding disorders.
    Rodríguez MF
    Blood Coagul Fibrinolysis; 2022 Jan; 33(Suppl 1):S15-S16. PubMed ID: 34654013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of rare factor deficiencies other than hemophilia.
    Menegatti M; Peyvandi F
    Blood; 2019 Jan; 133(5):415-424. PubMed ID: 30559262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coagulopathy with autoantibodies to blood-clotting factors: overview and laboratory diagnosis].
    Arai M
    Rinsho Byori; 2004 Feb; 52(2):178-81. PubMed ID: 15027324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired inhibitors of coagulation factors: part I-acquired hemophilia A.
    Coppola A; Favaloro EJ; Tufano A; Di Minno MN; Cerbone AM; Franchini M
    Semin Thromb Hemost; 2012 Jul; 38(5):433-46. PubMed ID: 22740182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune-mediated acquired coagulation factor deficiencies: state-of-the-art in diagnosis and management].
    Ichinose A
    Rinsho Ketsueki; 2019; 60(6):667-679. PubMed ID: 31281160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous inhibitors to coagulation factors.
    Green D
    Clin Lab Haematol; 2000 Oct; 22 Suppl 1():21-5; discussion 30-2. PubMed ID: 11251655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and diagnosis of coagulation disorders.
    Lusher JM
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 2):778-83. PubMed ID: 8828561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of the presentation of coagulation factor VIII inhibitors in rheumatic diseases: A potential cause of life-threatening hemorrhage.
    O'Connor CR
    Semin Arthritis Rheum; 2015 Jun; 44(6):695-709. PubMed ID: 25595725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving care and treatment options for women and girls with bleeding disorders.
    Kulkarni R
    Eur J Haematol; 2015 Dec; 95 Suppl 81():2-10. PubMed ID: 26679392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of rare congenital bleeding disorders.
    Dorgalaleh A; Bahraini M; Shams M; Parhizkari F; Dabbagh A; Naderi T; Fallah A; Fazeli A; Ahmadi SE; Samii A; Daneshi M; Heydari F; Tabibian S; Tavasoli B; Noroozi-Aghideh A; Tabatabaei T; Gholami MS
    Blood Rev; 2023 May; 59():101029. PubMed ID: 36369145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare bleeding disorders: worldwide efforts for classification, diagnosis, and management.
    Peyvandi F; Menegatti M; Palla R
    Semin Thromb Hemost; 2013 Sep; 39(6):579-84. PubMed ID: 23888434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India.
    Viswabandya A; Baidya S; Nair SC; Abraham A; George B; Mathews V; Chandy M; Srivastava A
    Haemophilia; 2012 May; 18(3):e195-200. PubMed ID: 22221743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation.
    Bolton-Maggs PH; Perry DJ; Chalmers EA; Parapia LA; Wilde JT; Williams MD; Collins PW; Kitchen S; Dolan G; Mumford AD
    Haemophilia; 2004 Sep; 10(5):593-628. PubMed ID: 15357789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Severe Acquired Haemophilia A with Immunosuppressive Agent: A Case Report of One Patient.
    Škunca Ž; Peraica AP
    Coll Antropol; 2016 Jun; 40(2):139-43. PubMed ID: 29139630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.